Panel session: moving towards the reality of a universal influenza vaccine

• Role for T cell response in preventing Flu disease
• Suitable antigens for universal Influenza vaccine
• Clinically validated vaccine vectors for universal influenza vaccine delivery

Dr. Melissa Malhame

Melissa Malhame., MBA is the Sr. Director of Marketing and Product Management at Dynavax Technologies. Melissa has been in the vaccine industry for 15 years in marketing, sales and business...

more..

Dr Jaap Goudsmit

Dr Jaap Goudsmit is Crucell’s Chief Scientific Officer and is responsible for all R&D activities. He became a member of Crucell’s Management Board in January 2004. He joined Crucell in 2001 as Senior ...

more..

Dr. Sarah Gilbert

After a first degree in Biological Sciences at the University of East Anglia and a PhD in Biochemistry (University of Hull) Dr Gilbert worked on metabolism and heterologous protein production in...

more..